KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Change in Cash: 2012-2024

Historic Change in Cash for Xenon Pharmaceuticals (XENE) over the last 13 years, with Dec 2024 value amounting to -$5.9 million.

  • Xenon Pharmaceuticals' Change in Cash rose 37.15% to -$30.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.9 million, marking a year-over-year increase of 241.33%. This contributed to the annual value of -$5.9 million for FY2024, which is 106.49% down from last year.
  • According to the latest figures from FY2024, Xenon Pharmaceuticals' Change in Cash is -$5.9 million, which was down 106.49% from $91.4 million recorded in FY2023.
  • Xenon Pharmaceuticals' 5-year Change in Cash high stood at $130.7 million for FY2021, and its period low was -$118.4 million during FY2022.
  • For the 3-year period, Xenon Pharmaceuticals' Change in Cash averaged around -$11.0 million, with its median value being -$5.9 million (2024).
  • Per our database at Business Quant, Xenon Pharmaceuticals' Change in Cash skyrocketed by 545.20% in 2021 and then plummeted by 190.64% in 2022.
  • Xenon Pharmaceuticals' Change in Cash (Yearly) stood at $20.3 million in 2020, then soared by 545.20% to $130.7 million in 2021, then plummeted by 190.64% to -$118.4 million in 2022, then spiked by 177.17% to $91.4 million in 2023, then slumped by 106.49% to -$5.9 million in 2024.